Clinical Trials on CD19-ALL

Total 438590 results

Ascentage Pharma Group Inc.

Recruiting

Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL

CLL/SLL

United States, Australia
DKMS gemeinnützige GmbH

Active, not recruiting

Haploidentical Donor vs mMUD in Hematological Malignancies (HAMLET)

AML | MDS | ALL

Germany
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Lenalidomide in Combination With CHOP in Patients With Untreated PTCL

PTCL, NOS | AITL | ALK- ALCL | Phase III-IV ALK+ ALCL | EATL

China
Duke University

Terminated

Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft

MDS | NHL | ALL | ANLL
Rhode Island Hospital

Completed

GAPcare Fall Prevention Pilot Survey

Fall

United States
Carbiogene Therapeutics Co. Ltd.
Zhejiang Provincial People's Hospital

Recruiting

Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)

AML M5 | AML M4

China
Daiichi Sankyo Co., Ltd.

Completed

Phase 1 Study of Quizartinib

Relapsed AML | Refractory AML

Japan
University of Birmingham

Completed

A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100) (PARC)

Cancer | Pediatric ALL | Pediatric Solid Tumor | Pediatric AML

United Kingdom, Australia, Netherlands
Riphah International University

Completed

Translation and Validation of the Performance Oriented Mobility Assessment (Poma) Scale Into Urdu Version

Fall

Pakistan
Zhejiang University
Hangzhou Cheetah Cell Therapeutics Co., Ltd

Recruiting

NKG2D CAR-NK & r/rAML

AML

China
Beijing Immunochina Medical Science & Technology...

Not yet recruiting

Donor-derived CAR-T Cells in the Treatment of AML Patients

AML

China
Zhejiang University
Shanghai Zeke Biotechnology Co.，Ltd

Terminated

NK Cell Therapy for AML

AML

China
PETHEMA Foundation

Completed

Epidemiologic Registry PETHEMA LMA 2013

AML

Spain
Aalborg University Hospital
Aalborg University

Suspended

Effect of Rhythm-based Multitask Training on Falls Among Older Adults (RYMA)

Fall Injury | Accidental Fall

Denmark
Seattle Children's Hospital
Children's Healthcare of Atlanta; Pediatric Oncology Experimental Therapeutics...

Completed

POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients

AML | Acute Leukemia of Ambiguous Lineage | ALL | Relapsed/Refractory AML | Relapsed/Refractory ALL | Secondary AML/MDS

United States, Canada
PETHEMA Foundation

Recruiting

Epidemiologic Registry PETHEMA LMA 2015

AML

Spain
Hospital Universitario Dr. Jose E. Gonzalez

Completed

Low-dose Venetoclax and Azacitidine as Front-line Therapy in Newly Diagnosed AML

AML

Mexico
National Institute of Environmental Health Sciences...

Completed

Exposure to Neurotoxins as Risk Factors for ALS

ALS

United States
Rambam Health Care Campus

Unknown

Rapid Profiling of Bone Marrow, at Presentation and After 5 Days of Induction Therapy

AML

Israel
Zhejiang University

Not yet recruiting

Evaluate the Safety and Efficacy of CD33 CAR-T in Patients With R/R AML

AML

China
Zhejiang University

Not yet recruiting

Evaluate the Safety and Efficacy of CLL1 CAR-T in Patients With R/R AML

AML

China
Zhejiang University

Not yet recruiting

Evaluate the Safety and Efficacy of CLL1+CD33 CAR-T in Patients With R/R AML

AML

China
Zhejiang University

Not yet recruiting

Evaluate the Safety and Efficacy of ADGRE2 CAR-T in Patients With R/R AML

AML

China
Aptevo Therapeutics

Withdrawn

Study of APVO436 in Elderly or Unfit Patients With Newly Diagnosed AML

AML
Martin-Luther-Universität Halle-Wittenberg

Unknown

Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatment is Possible (TCP-AML)

AML

Germany
Nantes University Hospital

Completed

High-Dose Imatinib for Relapsed/Refractory c-Kit Positive Acute Myelogenous Leukemia (AML)

AML

France
BioNova Pharmaceuticals (Shanghai) LTD.

Recruiting

A Study of BN104 in the Treatment of Acute Leukemia

AML, Adult | ALL, Adult

China
Zhejiang University
Hangzhou Qihangene Biotech Co.,Ltd.

Recruiting

Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia

AML, Adult

China
Gruppo Italiano Malattie EMatologiche dell'Adulto

Recruiting

Novel Approaches to Target MECOM/EVI1 in AML

AML, Adult

Italy
BioSight Ltd.

Recruiting

A Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagnosed AML

AML, Adult

United States
Zhejiang University
Hangzhou Qihan Biotech Co.,Ltd.

Recruiting

Natural Killer(NK) Cell Therapy in r/r AML

AML, Adult

China
Stichting Hemato-Oncologie voor Volwassenen Nederland

Recruiting

A Trial to Assess Cobicistat Boosted Venetoclax in Combination With Azacitidine in Adult Patients With Newly Diagnosed AML (HO171)

AML, Adult

Netherlands
NYU Langone Health

Completed

The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction

ACL

United States
Therapeutic Advances in Childhood Leukemia Consortium
Bristol-Myers Squibb

Active, not recruiting

Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML

AML, Childhood

United States
MedicusTek USA Corporation
Kaiser Permanente

Completed

Sensable®Care System: Establishing a Communications System for Patient Fall Reduction

Fall From Bed

United States
OPKO Health, Inc.

Completed

Efficacy and Tolerability of a Nutritional Supplement, Plactive Progen, in ACL Reconstruction

ACL Reconstruction
McGill University

Completed

Risk of Falls in Patients Attending Music Sessions on an Acute Geriatric Ward

Fall | Aged | Music

Canada
Cleveland State University

Suspended

Simple Fall-Arrest Harness vs. Adjustable Harness

Fall Injury | Balancing Interference | Fall Accident

United States
Niguarda Hospital

Active, not recruiting

ObinutuzuMab AtezOlizumab and VenetocLax in RichTer transfOrmation (MOLTO)

CLL Transformation

Italy, Switzerland
Stichting Hemato-Oncologie voor Volwassenen Nederland
Nordic Lymphoma Group

Active, not recruiting

CLL Induction Treatment With Venetoclax and Ibrutinib, Followed by Ibrutinib and Obinutuzumab in Patients With MRD.

CLL

Netherlands, Denmark
T.C. ORDU ÜNİVERSİTESİ

Completed

Turkish Version of Fear of Falling Avoidance Behavior Questionnaire

Fall | Older People | Fear

Turkey
Clavis Pharma
Syneos Health; Theradex; CardiaBase; Learn & Confirm

Completed

The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055)

Relapsed/Refractory AML

United Kingdom, Spain
The First Hospital of Jilin University

Active, not recruiting

Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT

Relapsed Adult AML | Relapsed Adult ALL

China
University of Aarhus
Central Denmark Region

Withdrawn

Videoconferencing Between Ambulances and Physician Manned Rapid Response Vehicles, Effects on On-site Patient Treatment and Patterns of Referral

All Acutely Ill or Injured Patients Receiving Care by Ambulance Personnel

Denmark
Centre of Postgraduate Medical Education

Recruiting

ACL Reconstruction With/Without ALL Reconstruction

ACL Injury | ALL

Poland
McMaster University

Completed

Home-based HIFST for Older Adults to Prevent Functional Decline

Mobility Limitation | Fall Injury | Slip and Fall

Canada
Apollomics Inc.
Zhejiang CrownMab Biotech Co. Ltd

Recruiting

Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML

Relapsed/Refractory AML

China
University of Iowa
Centers for Disease Control and Prevention

Recruiting

Medication Empowerment and Deprescription for Safety (MEDS) Study (MEDS)

Aging | Fall Injury

United States
Pacira CryoTech, Inc., a wholly owned subsidiary...

Withdrawn

Evaluate the Iovera° Device in Treating Pain Associated With Anterior Cruciate Ligament Reconstruction

ACL Reconstruction
University Hospital, Angers

Completed

Older falleRs : From Emergency to Geriatric Network (OREGoN)

Fall Patients

France

Clinical Trials on CD19-ALL

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations